Xtant Medical logo

Xtant Medical share price today

(XTNT)

Xtant Medical share price is $0.51 & ₹43.76 as on 7 Jan 2025, 2.30 'hrs' IST

$0.51

-0.01

(-2.62%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Xtant Medical share price in Dollar and Rupees. Guide to invest in Xtant Medical stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Xtant Medical, along with analyst recommendations, forecasts, and comprehensive financials.

Xtant Medical share price movements

  • Today's Low: $0.50
    Today's High: $0.58

    Day's Volatility :13.99%

  • 52 Weeks Low: $0.33
    52 Weeks High: $1.30

    52 Weeks Volatility :74.54%

Xtant Medical Returns

PeriodXtant Medical Holdings IncIndex (Russel 2000)
3 Months
-18.42%
0.0%
6 Months
-19.66%
0.0%
1 Year
-54.57%
0.0%
3 Years
-10.06%
-19.8%

Xtant Medical Key Statistics

in dollars & INR

Previous Close
$0.527
Open
$0.567
Today's High
$0.579
Today's Low
$0.498
Market Capitalization
$61.6M
Today's Volume
$221.5K
52 Week High
$1.3
52 Week Low
$0.331
Revenue TTM
$110.9M
EBITDA
$-9.7M
Earnings Per Share (EPS)
$-0.13
Profit Margin
-3.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-8.77%

How to invest in Xtant Medical from India?

It is very easy for Indian residents to invest directly in Xtant Medical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xtant Medical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xtant Medical or XTNT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xtant Medical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xtant Medical shares which would translate to 1.683 fractional shares of Xtant Medical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Xtant Medical, in just a few clicks!

Returns in Xtant Medical for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xtant Medical investment value today

Current value as on today

₹47,188

Returns

₹52,812

(-52.81%)

Returns from Xtant Medical Stock

₹56,034 (-56.03%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Xtant Medical

-3%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Xtant Medical on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -3% less investors are searching Xtant Medical in the last 30 days versus the previous period.

Analyst Recommendation on Xtant Medical

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Xtant Medical(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Xtant Medical

What analysts predicted

Upside of 341.18%

Current:

$0.51

Target:

$2.25

Insights on Xtant Medical

  • Price Movement

    In the last 7 days, XTNT stock has moved up by 15.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 29.94M → 27.93M (in $), with an average decrease of 6.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -3.86M → -5.02M (in $), with an average decrease of 30.1% per quarter
  • XTNT vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 55.9% return, outperforming this stock by 111.6%
  • XTNT vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 112.9% return, outperforming this stock by 124.5%
  • Price to Sales

    ForXTNT every $1 of sales, investors are willing to pay $0.6, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Xtant Medical Financials in INR & Dollars

FY18Y/Y Change
Revenue
$72.2M
↓ 12.6%
Net Income
$-70.1M
↑ 33.75%
Net Profit Margin
-97.09%
↓ 33.65%
FY19Y/Y Change
Revenue
$64.7M
↓ 10.42%
Net Income
$-8.2M
↓ 88.27%
Net Profit Margin
-12.71%
↑ 84.38%
FY20Y/Y Change
Revenue
$53.3M
↓ 17.54%
Net Income
$-7.0M
↓ 14.57%
Net Profit Margin
-13.17%
↓ 0.46%
FY21Y/Y Change
Revenue
$55.3M
↑ 3.61%
Net Income
$-5.8M
↓ 16.79%
Net Profit Margin
-10.57%
↑ 2.6%
FY22Y/Y Change
Revenue
$58.0M
↑ 4.9%
Net Income
$-8.5M
↑ 45.19%
Net Profit Margin
-14.64%
↓ 4.07%
FY23Y/Y Change
Revenue
$91.3M
↑ 57.5%
Net Income
$660.0K
↓ 107.78%
Net Profit Margin
0.72%
↑ 15.36%
Q2 FY23Q/Q Change
Revenue
$20.2M
↑ 12.76%
Net Income
$-2.2M
↑ 5.39%
Net Profit Margin
-10.82%
↑ 0.76%
Q3 FY23Q/Q Change
Revenue
$25.0M
↑ 23.66%
Net Income
$9.2M
↓ 521.51%
Net Profit Margin
36.9%
↑ 47.72%
Q4 FY23Q/Q Change
Revenue
$28.1M
↑ 12.35%
Net Income
$-4.3M
↓ 146.61%
Net Profit Margin
-15.31%
↓ 52.21%
Q1 FY24Q/Q Change
Revenue
$27.9M
↓ 0.84%
Net Income
$-4.4M
↑ 2.25%
Net Profit Margin
-15.79%
↓ 0.48%
Q2 FY24Q/Q Change
Revenue
$29.9M
↑ 7.43%
Net Income
$-3.9M
↓ 12.25%
Net Profit Margin
-12.89%
↑ 2.9%
Q3 FY24Q/Q Change
Revenue
$27.9M
↓ 6.7%
Net Income
$-5.0M
↑ 30.12%
Net Profit Margin
-17.98%
↓ 5.09%
FY18Y/Y Change
Profit
$43.5M
↓ 13.2%
FY19Y/Y Change
Profit
$42.5M
↓ 2.23%
FY20Y/Y Change
Profit
$34.4M
↓ 19.11%
FY21Y/Y Change
Profit
$32.5M
↓ 5.53%
FY22Y/Y Change
Profit
$32.1M
↓ 1.09%
FY23Y/Y Change
Profit
$55.5M
↑ 72.6%
Q2 FY23Q/Q Change
Profit
$12.5M
↑ 18.25%
Q3 FY23Q/Q Change
Profit
$15.3M
↑ 23.08%
Q4 FY23Q/Q Change
Profit
$17.1M
↑ 11.76%
Q1 FY24Q/Q Change
Profit
$17.3M
↑ 0.96%
Q2 FY24Q/Q Change
Profit
$18.6M
↑ 7.4%
Q3 FY24Q/Q Change
Profit
$16.3M
↓ 12.24%
FY18Y/Y Change
Operating Cash Flow
$1.2M
↓ 323.13%
Investing Cash Flow
$-367.0K
↓ 77.18%
Financing Cash Flow
$3.1M
↑ 27.46%
FY19Y/Y Change
Operating Cash Flow
$-413.0K
↓ 134.08%
Investing Cash Flow
$-544.0K
↑ 48.23%
Financing Cash Flow
$-603.0K
↓ 119.48%
FY20Y/Y Change
Operating Cash Flow
$-731.0K
↑ 77.0%
Investing Cash Flow
$-1.3M
↑ 139.71%
Financing Cash Flow
$-861.0K
↑ 42.79%
FY21Y/Y Change
Operating Cash Flow
$439.0K
↓ 160.05%
Investing Cash Flow
$-1.9M
↑ 44.94%
Financing Cash Flow
$17.5M
↓ 2132.17%
FY22Y/Y Change
Operating Cash Flow
$-5.3M
↓ 1316.63%
Investing Cash Flow
$-1.6M
↓ 17.51%
Financing Cash Flow
$9.0M
↓ 48.45%
Q2 FY23Q/Q Change
Operating Cash Flow
$-2.5M
↑ 12.29%
Investing Cash Flow
$-394.0K
↓ 97.74%
Financing Cash Flow
$2.0M
↓ 57.26%

Xtant Medical Technicals Summary

Sell

Neutral

Buy

Xtant Medical is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Xtant Medical Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Xtant Medical Holdings Inc
34.51%
-19.66%
-54.57%
-10.06%
-67.06%
Stryker Corporation
-5.14%
7.73%
20.51%
37.02%
70.83%
Boston Scientific Corp.
2.22%
18.53%
55.24%
113.84%
98.4%
Edwards Lifesciences Corp.
4.25%
-20.93%
-2.33%
-38.47%
-5.21%
Abbott Laboratories
-0.93%
11.99%
1.27%
-15.84%
31.69%
Medtronic Plc
-3.59%
5.29%
-6.49%
-23.36%
-31.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Xtant Medical Holdings Inc
0.0
NA
-0.03
-0.12
-0.09
-0.11
NA
0.39
Stryker Corporation
38.59
38.59
2.51
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
73.82
73.82
1.62
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
28.0
28.0
6.67
2.54
0.19
0.11
NA
16.18
Abbott Laboratories
34.38
34.38
2.19
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
24.43
24.43
1.46
5.45
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Xtant Medical Holdings Inc
Buy
$61.6M
-67.06%
0.0
-3.0%
Stryker Corporation
Buy
$137.3B
70.83%
38.59
16.34%
Boston Scientific Corp.
Buy
$131.6B
98.4%
73.82
11.26%
Edwards Lifesciences Corp.
Buy
$43.6B
-5.21%
28.0
65.86%
Abbott Laboratories
Buy
$196.2B
31.69%
34.38
13.99%
Medtronic Plc
Buy
$102.4B
-31.62%
24.43
12.06%

About Xtant Medical

xtant medical (nyse mkt: xtnt) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. with core competencies in both biologic and non-biologic surgical technologies, xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. for further information, please visit xtantmedical.com.
Organization
Xtant Medical
Employees
207
CEO
Mr. Sean E. Browne
Industry
Health Technology

Management People of Xtant Medical

NameTitle
Mr. Sean E. Browne
President, CEO & Director
Mr. Mark A. Schallenberger
Chief Operations Officer
Mr. Scott C. Neils
Chief Financial Officer
Ms. Catherine Lundy
Vice President of Human Resources

Important FAQs about investing in Xtant Medical from India :

What is Xtant Medical share price today?

Xtant Medical share price today stands at $0.51, Open: $0.57 ; Previous Close: $0.53 ; High: $0.58 ; Low: $0.50 ; 52 Week High: $1.30 ; 52 Week Low: $0.33. The stock opens at $0.57, after a previous close of $0.53. The stock reached a daily high of $0.58 and a low of $0.50, with a 52-week high of $1.30 and a 52-week low of $0.33.

Can Indians buy Xtant Medical shares?

Yes, Indians can invest in the Xtant Medical (XTNT) from India.

With INDmoney, you can buy Xtant Medical at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Xtant Medical at zero transaction cost.

How can I buy Xtant Medical shares from India?

It is very easy to buy Xtant Medical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xtant Medical be purchased?

Yes, you can buy fractional shares of Xtant Medical with INDmoney app.

What are the documents required to start investing in Xtant Medical stocks?

To start investing in Xtant Medical, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Xtant Medical

Today’s highest price of Xtant Medical (XTNT) is $0.58.

Today’s lowest price of Xtant Medical (XTNT) is $0.50.

What is today's market capitalisation of Xtant Medical

Today's market capitalisation of Xtant Medical XTNT is 61.6M

What is the 52 Week High and Low Range of Xtant Medical

  • 52 Week High

    $1.30

  • 52 Week Low

    $0.33

What are the historical returns of Xtant Medical?

  • 1 Month Returns

    34.51%

  • 3 Months Returns

    -19.66%

  • 1 Year Returns

    -54.57%

  • 5 Years Returns

    -67.06%

Who is the Chief Executive Officer (CEO) of Xtant Medical

Mr. Sean E. Browne is the current Chief Executive Officer (CEO) of Xtant Medical.